BEAM
Price
$24.10
Change
+$0.20 (+0.84%)
Updated
Apr 22, 6:59 PM EST
14 days until earnings call
FATE
Price
$4.78
Change
-$0.01 (-0.21%)
Updated
Apr 22, 6:59 PM EST
8 days until earnings call
Ad is loading...

Analysis and predictions BEAM vs FATE

Header iconBEAM vs FATE Comparison
Open Charts BEAM vs FATEBanner chart's image
Beam Therapeutics
Price$24.10
Change+$0.20 (+0.84%)
Volume$1.13M
CapitalizationN/A
Fate Therapeutics
Price$4.78
Change-$0.01 (-0.21%)
Volume$730.09K
CapitalizationN/A
View a ticker or compare two or three
BEAM vs FATE Comparison Chart

Loading...

BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
FATEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BEAM vs. FATE commentary
Apr 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongSell and FATE is a Hold.

COMPARISON
Comparison
Apr 23, 2024
Stock price -- (BEAM: $24.10 vs. FATE: $4.78)
Brand notoriety: BEAM and FATE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 157% vs. FATE: 58%
Market capitalization -- BEAM: $1.98B vs. FATE: $544.91M
BEAM [@Biotechnology] is valued at $1.98B. FATE’s [@Biotechnology] market capitalization is $544.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $557.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.53B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileFATE’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • FATE’s FA Score: 1 green, 4 red.
According to our system of comparison, FATE is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 2 TA indicator(s) are bullish while FATE’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 2 bullish, 4 bearish.
  • FATE’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both BEAM and FATE are a bad buy in the short-term.

Price Growth

BEAM (@Biotechnology) experienced а -6.23% price change this week, while FATE (@Biotechnology) price change was -15.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.60%. For the same industry, the average monthly price growth was -5.24%, and the average quarterly price growth was +1242.63%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 06, 2024.

FATE is expected to report earnings on Jul 31, 2024.

Industries' Descriptions

@Biotechnology (-3.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BEAM with price predictions.
OPEN
A.I.dvisor published
a Summary for FATE with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BEAM($1.98B) has a higher market cap than FATE($545M). FATE YTD gains are higher at: 27.807 vs. BEAM (-11.462).
BEAMFATEBEAM / FATE
Capitalization1.98B545M364%
EBITDAN/AN/A-
Gain YTD-11.46227.807-41%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMFATE
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 8 days ago
87%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
FATEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ANTUX9.260.14
+1.54%
American Century Non-US IntrsVal Inv
GCIUX14.440.17
+1.19%
Goldman Sachs Intl Eq Insghts R6
VSSWX37.680.41
+1.10%
JPMorgan Small Cap Sustainable Ldrs I
APHHX19.900.15
+0.76%
Artisan Global Equity Institutional
MSFFX19.180.11
+0.58%
MFS Total Return R1

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with NTLA. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+0.84%
NTLA - BEAM
77%
Closely correlated
+1.21%
CRSP - BEAM
69%
Closely correlated
+1.11%
DNLI - BEAM
69%
Closely correlated
-0.06%
EDIT - BEAM
63%
Loosely correlated
+2.00%
PRME - BEAM
62%
Loosely correlated
+5.99%
More

FATE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FATE has been loosely correlated with PIRS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if FATE jumps, then PIRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FATE
1D Price
Change %
FATE100%
-0.21%
PIRS - FATE
51%
Loosely correlated
+0.76%
NTLA - FATE
50%
Loosely correlated
+1.21%
XNCR - FATE
47%
Loosely correlated
-0.92%
ABCL - FATE
47%
Loosely correlated
+3.62%
BEAM - FATE
46%
Loosely correlated
+0.84%
More